ClinicalTrials.Veeva

Menu

CHARM-COPD Program of Care

University Health Network, Toronto logo

University Health Network, Toronto

Status

Enrolling

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Behavioral: Audio recording
Device: Home Spirometer
Device: Hyfe Smartwatch
Device: FitBit Versa 2

Study type

Interventional

Funder types

Other

Identifiers

NCT06253013
23-5062

Details and patient eligibility

About

The investigators' goal for this project is to evaluate the feasibility, acceptability, and actual usage of a program of care for patients with COPD recently discharged after an acute exacerbation. The program of care includes virtual pulmonary rehabilitation, integrated care, and remote clinical monitoring.

Full description

The investigators' goal for this project is to evaluate the feasibility, acceptability, and actual usage of a multimodal, individualized program of care for patients with COPD recently discharged from hospital with an acute exacerbation. The program will combine elements of existing standards of care at two institutions, Toronto Grace Health Centre and University Health Network, with emerging technologies.

The investigators want to determine whether the program is considered appropriate and useful to both patients and health care providers, and whether it is feasible to implement. The investigators also want to determine whether it is feasible to conduct a large-scale randomized control trial of the program. The investigators will also explore whether each intervention reduces re-admissions to hospital.

Enrollment

100 estimated patients

Sex

All

Ages

40+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Referred to either Virtual Pulmonary Rehabilitation or Remote Clinical Monitoring at Toronto Grace Health Centre after discharge from UHN hospital with an AECOPD as defined by the clinical team

Exclusion criteria

  • Pulmonary condition other than COPD as the main respiratory disease such as bronchiectasis or asthma
  • Projected life expectancy ≤ 2 months , as determined by the clinical team
  • Significant cognitive impairment and absence/inability of a family caregiver to consent and to follow study processes

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

100 participants in 1 patient group

Full study intervention
Experimental group
Description:
In addition to the standard of care at the institutions which includes virtual pulmonary rehabilitation, remote clinical monitoring and integrated care, patients will have the option to use the following interventions: * FitBit wearable device with continuous monitoring for oxygen saturation and respiratory rate for 90 days * Hyfe cough monitoring smartwatch with continuous monitoring for 90 days * Home spirometer used once daily for 90 days * Audio recordings on a tablet once daily for 90 days
Treatment:
Device: FitBit Versa 2
Device: Hyfe Smartwatch
Device: Home Spirometer
Behavioral: Audio recording

Trial contacts and locations

1

Loading...

Central trial contact

Robert Wu, MD; Alice Tu, MA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems